Synapse Medicine provides clinical decision support technology for medication management, offering AI-powered tools that integrate seamlessly into EHR systems, e-prescribing software, and clinical workflows. The platform aggregates official drug databases and uses reliable AI algorithms to deliver personalized clinical decision support, helping healthcare professionals make smarter and faster medication decisions. Synapse Medicine offers React Native components and APIs for easy integration, with ONC-certified health IT modules. Founded in 2017 and headquartered in Bordeaux, France, the company has raised approximately $39.2M in Series B funding. Synapse Medicine differentiates itself through its R&D-driven approach, dedicated customer success team, and seamless integration capabilities. The platform serves healthcare providers, telemedicine companies, hospitals, and healthcare facilities, with partnerships including CGM, Hellocare, and Lifen.
Synapse Medicine
Series BSynapse Medicine provides clinical decision support technology for medication management, offering AI-powered tools that integrate seamlessly into EHR systems, e-prescribing software, and clinical workflows. The platform aggregates official drug databases and uses reliable AI algorithms to deliver personalized clinical decision support, helping healthcare professionals make smarter and faster medication decisions.…
About
Business model
Chatbots > Industry Specific > Healthcare > Medical Practitioners > Medication Adherence,
Disease Self Management > Medication Adherence > App,
Healthcare IT > Value Based Care > Patient Engagement > Medication Adherence,
Pharmacy IT > Dispensing Management > Prescription Errors Monitoring
Institutional investors
Latest coverage
📰 Browse funding news — rounds, valuations, and market moves for founders.
Backed by funds in our directory
🗂️ Full list of active funds — filter by stage, check size, and geography.